Poland· PL-100093978

Doxar

A g04ca, c02ca04 product containing doxazosinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o..

ATC G04CA, C02CA04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDoxarATCG04CA, C02CA04REGISTER NO.PL-100093978PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Doxazosinum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
G04CA, C02CA04
ATC class
G04CA, C02CA04
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    05909990485017
    30 szt.
    PLN 19

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Doxazosinum in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxazosinum products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Ascalan, Doxazosin 1a Pharma
  • Bulgaria · Доксазосин Чайкафарма, Зоксон
  • Cyprus · Cardura, Magurol
  • Czechia · Doxazosin G.L. Pharma, Kamiren
  • Germany · Cardular, Cardular Pp
  • Denmark · Cardosin Retard, Carduran Retard
  • Estonia · Cardura, Cardura Xl
  • Spain · Carduran Neo, Doxazosina Alter
  • France · Doxazosine L.P. Viatris, Doxazosine Lp Arrow
  • United Kingdom (Northern Ireland) · Cardura, Cardura Xl
  • Greece · Cardura, Maguran
  • Croatia · Doxa, Doxazin
  • Hungary · Cardura, Cardura Xl
  • Ireland · Cardura, Cardura Xl
  • Iceland · Cardosin Retard, Carduran Retard
  • Italy · Benur, Cardura
  • Lithuania · Cardura, Cardura Xl
  • Latvia · Cardura, Cardura Xl
  • Malta · Cardura, Doxatan
  • Netherlands · Cardura Xl, Doxazosin Syri Pharma
  • Norway · Carduran Cr
  • Portugal · Cardura Gits, Doxazosina Generis
  • Romania · Cardura Xl, Doxazosin Arena
  • Sweden · Alfadil, Alfadil Bph
  • Slovenia · Cardura Xl, Kamiren
  • Slovakia · Kamiren Xl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af7ee6e1-f4cc-48ec-a901-1c0a6639d893
GET /v1/drugs/af7ee6e1-f4cc-48ec-a901-1c0a6639d893?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "05909990485017 ¦ Rp ¦ 15554\n30 tabl.",
  "substance": "Doxazosini mesilas 2 mg",
  "common_name": "Doxazosinum",
  "pl_product_id": "100093978",
  "pozwolenie_nr": "04850",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about doxazosinum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.